Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, Barzin Y. Nabet et al.|Cancer Cell|2021Cited by 930
The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour DurabilityRoddy S. O’Connor, Saar Gill, Bakir Valentić et al.|Research Square|2024Cited by 5
List of ContributorsEliana Abdelhay, Farhadul Islam, Pavan P. Adiseshaiah et al.|Elsevier eBooks|2018Cited by 0